SPY415.21-2.05 -0.49%
DIA340.75-1.11 -0.32%
IXIC13,914.77-137.58 -0.98%

CTI BioPharma Q4 EPS $(0.20) Misses $(0.16) Estimate

CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 42.86 percent decrease over losses of $(0.14) per share from the

· 03/17/2021 16:07
CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 42.86 percent decrease over losses of $(0.14) per share from the same period last year.